The Xia group is pursuing cutting-edge research in three major frontiers: nanotechnology, materials chemistry, and photonic devices. Recently, the group starts to move into cell biology by harnessing the power of nanomaterials to develop novel tools for studying complex biological systems.
The University of Missouri - International Institute of Nano and Molecular Medicine is a campus wide research center dedicated to the discovery and application of fundamental and translational medical science based upon previously unexplored chemistry combined with nanotechnology and the biosciences.
In 2005, the National Cancer Institute (NCI) recognized Washington University School of Medicine's contribution to nanomedicine with a five-year, $16 million grant to establish the Siteman Center of Cancer Nanotechnology Excellence (SCCNE). It is one of eight such centers funded by the NCI in the United States.
The lab's research interests are focused at the intersection organic and plasmonic nanomaterials. They aim at rational integration of organic (polymeric, biological) materials and plasmonic nanostructures to realize multifunctional materials. Organic materials with responsive and self-assembling properties combined with functional plasmonic nanostructures that exhibit unique optical properties forms a powerful materials platform for a wide variety of applications including plasmonic photovoltaics, chemical and biological sensors, adaptive materials, non- or minimally-invasive bioimging and therapy.